Oncology API (Active Pharmaceutical Ingredient) refers to the active substances used in the formulation of drugs specifically for the treatment of cancer. These APIs are used to target and treat various types of cancer through different mechanisms of action. They include chemotherapy agents, targeted therapies, hormonal treatments, and immunotherapies, each with specific mechanisms of action. The development, manufacturing, and regulatory oversight of these APIs are critical to ensuring their safety, efficacy, and availability for cancer patients.
The global Oncology API market was valued at US$ 2000 million in 2023 and is anticipated to reach US$ 3212 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
North American market for Oncology API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oncology API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oncology API include Olon Group, PolyPeptide, Glenmark Life Sciences, Sterling, Neopharma, Concord Biotech, Eisai Pharmaceuticals, Aspen API, Dr. Reddy's, CordenPharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncology API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology API.
The Oncology API market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oncology API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Olon Group
PolyPeptide
Glenmark Life Sciences
Sterling
Neopharma
Concord Biotech
Eisai Pharmaceuticals
Aspen API
Dr. Reddy's
CordenPharma
Natco
PROCOS SPA
Biocon
Shivalik Rasayan
Kekule Pharma
Aenova
GLS Pharma
Suanfarma
Fresenius Kabi Oncology
Hetero
Bachem
Segment by Type
Alkylating Agents
Antimetabolites
Others
Segment by Application
Chemotherapy
Targeted Therapy
Immunotherapy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oncology API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oncology API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Oncology API Market Overview
1.1 Product Definition
1.2 Oncology API by Type
1.2.1 Global Oncology API Market Value Comparison by Type (2024-2030)
1.2.2 Alkylating Agents
1.2.3 Antimetabolites
1.2.4 Others
1.3 Oncology API by Application
1.3.1 Global Oncology API Market Value by Application (2024-2030)
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Global Oncology API Market Size Estimates and Forecasts
1.4.1 Global Oncology API Revenue 2019-2030
1.4.2 Global Oncology API Sales 2019-2030
1.4.3 Global Oncology API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oncology API Market Competition by Manufacturers
2.1 Global Oncology API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oncology API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oncology API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oncology API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncology API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology API, Product Type & Application
2.7 Global Key Manufacturers of Oncology API, Date of Enter into This Industry
2.8 Global Oncology API Market Competitive Situation and Trends
2.8.1 Global Oncology API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oncology API Players Market Share by Revenue
2.8.3 Global Oncology API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oncology API Market Scenario by Region
3.1 Global Oncology API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oncology API Sales by Region: 2019-2030
3.2.1 Global Oncology API Sales by Region: 2019-2024
3.2.2 Global Oncology API Sales by Region: 2025-2030
3.3 Global Oncology API Revenue by Region: 2019-2030
3.3.1 Global Oncology API Revenue by Region: 2019-2024
3.3.2 Global Oncology API Revenue by Region: 2025-2030
3.4 North America Oncology API Market Facts & Figures by Country
3.4.1 North America Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oncology API Sales by Country (2019-2030)
3.4.3 North America Oncology API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncology API Market Facts & Figures by Country
3.5.1 Europe Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oncology API Sales by Country (2019-2030)
3.5.3 Europe Oncology API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology API Market Facts & Figures by Region
3.6.1 Asia Pacific Oncology API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oncology API Sales by Region (2019-2030)
3.6.3 Asia Pacific Oncology API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncology API Market Facts & Figures by Country
3.7.1 Latin America Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oncology API Sales by Country (2019-2030)
3.7.3 Latin America Oncology API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oncology API Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oncology API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oncology API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncology API Sales by Type (2019-2030)
4.1.1 Global Oncology API Sales by Type (2019-2024)
4.1.2 Global Oncology API Sales by Type (2025-2030)
4.1.3 Global Oncology API Sales Market Share by Type (2019-2030)
4.2 Global Oncology API Revenue by Type (2019-2030)
4.2.1 Global Oncology API Revenue by Type (2019-2024)
4.2.2 Global Oncology API Revenue by Type (2025-2030)
4.2.3 Global Oncology API Revenue Market Share by Type (2019-2030)
4.3 Global Oncology API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oncology API Sales by Application (2019-2030)
5.1.1 Global Oncology API Sales by Application (2019-2024)
5.1.2 Global Oncology API Sales by Application (2025-2030)
5.1.3 Global Oncology API Sales Market Share by Application (2019-2030)
5.2 Global Oncology API Revenue by Application (2019-2030)
5.2.1 Global Oncology API Revenue by Application (2019-2024)
5.2.2 Global Oncology API Revenue by Application (2025-2030)
5.2.3 Global Oncology API Revenue Market Share by Application (2019-2030)
5.3 Global Oncology API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Olon Group
6.1.1 Olon Group Company Information
6.1.2 Olon Group Description and Business Overview
6.1.3 Olon Group Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Olon Group Oncology API Product Portfolio
6.1.5 Olon Group Recent Developments/Updates
6.2 PolyPeptide
6.2.1 PolyPeptide Company Information
6.2.2 PolyPeptide Description and Business Overview
6.2.3 PolyPeptide Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PolyPeptide Oncology API Product Portfolio
6.2.5 PolyPeptide Recent Developments/Updates
6.3 Glenmark Life Sciences
6.3.1 Glenmark Life Sciences Company Information
6.3.2 Glenmark Life Sciences Description and Business Overview
6.3.3 Glenmark Life Sciences Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glenmark Life Sciences Oncology API Product Portfolio
6.3.5 Glenmark Life Sciences Recent Developments/Updates
6.4 Sterling
6.4.1 Sterling Company Information
6.4.2 Sterling Description and Business Overview
6.4.3 Sterling Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sterling Oncology API Product Portfolio
6.4.5 Sterling Recent Developments/Updates
6.5 Neopharma
6.5.1 Neopharma Company Information
6.5.2 Neopharma Description and Business Overview
6.5.3 Neopharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Neopharma Oncology API Product Portfolio
6.5.5 Neopharma Recent Developments/Updates
6.6 Concord Biotech
6.6.1 Concord Biotech Company Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Concord Biotech Oncology API Product Portfolio
6.6.5 Concord Biotech Recent Developments/Updates
6.7 Eisai Pharmaceuticals
6.7.1 Eisai Pharmaceuticals Company Information
6.7.2 Eisai Pharmaceuticals Description and Business Overview
6.7.3 Eisai Pharmaceuticals Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Eisai Pharmaceuticals Oncology API Product Portfolio
6.7.5 Eisai Pharmaceuticals Recent Developments/Updates
6.8 Aspen API
6.8.1 Aspen API Company Information
6.8.2 Aspen API Description and Business Overview
6.8.3 Aspen API Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aspen API Oncology API Product Portfolio
6.8.5 Aspen API Recent Developments/Updates
6.9 Dr. Reddy's
6.9.1 Dr. Reddy's Company Information
6.9.2 Dr. Reddy's Description and Business Overview
6.9.3 Dr. Reddy's Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr. Reddy's Oncology API Product Portfolio
6.9.5 Dr. Reddy's Recent Developments/Updates
6.10 CordenPharma
6.10.1 CordenPharma Company Information
6.10.2 CordenPharma Description and Business Overview
6.10.3 CordenPharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CordenPharma Oncology API Product Portfolio
6.10.5 CordenPharma Recent Developments/Updates
6.11 Natco
6.11.1 Natco Company Information
6.11.2 Natco Description and Business Overview
6.11.3 Natco Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Natco Oncology API Product Portfolio
6.11.5 Natco Recent Developments/Updates
6.12 PROCOS SPA
6.12.1 PROCOS SPA Company Information
6.12.2 PROCOS SPA Description and Business Overview
6.12.3 PROCOS SPA Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PROCOS SPA Oncology API Product Portfolio
6.12.5 PROCOS SPA Recent Developments/Updates
6.13 Biocon
6.13.1 Biocon Company Information
6.13.2 Biocon Description and Business Overview
6.13.3 Biocon Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Biocon Oncology API Product Portfolio
6.13.5 Biocon Recent Developments/Updates
6.14 Shivalik Rasayan
6.14.1 Shivalik Rasayan Company Information
6.14.2 Shivalik Rasayan Description and Business Overview
6.14.3 Shivalik Rasayan Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shivalik Rasayan Oncology API Product Portfolio
6.14.5 Shivalik Rasayan Recent Developments/Updates
6.15 Kekule Pharma
6.15.1 Kekule Pharma Company Information
6.15.2 Kekule Pharma Description and Business Overview
6.15.3 Kekule Pharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Kekule Pharma Oncology API Product Portfolio
6.15.5 Kekule Pharma Recent Developments/Updates
6.16 Aenova
6.16.1 Aenova Company Information
6.16.2 Aenova Description and Business Overview
6.16.3 Aenova Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Aenova Oncology API Product Portfolio
6.16.5 Aenova Recent Developments/Updates
6.17 GLS Pharma
6.17.1 GLS Pharma Company Information
6.17.2 GLS Pharma Description and Business Overview
6.17.3 GLS Pharma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 GLS Pharma Oncology API Product Portfolio
6.17.5 GLS Pharma Recent Developments/Updates
6.18 Suanfarma
6.18.1 Suanfarma Company Information
6.18.2 Suanfarma Description and Business Overview
6.18.3 Suanfarma Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Suanfarma Oncology API Product Portfolio
6.18.5 Suanfarma Recent Developments/Updates
6.19 Fresenius Kabi Oncology
6.19.1 Fresenius Kabi Oncology Company Information
6.19.2 Fresenius Kabi Oncology Description and Business Overview
6.19.3 Fresenius Kabi Oncology Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Fresenius Kabi Oncology Oncology API Product Portfolio
6.19.5 Fresenius Kabi Oncology Recent Developments/Updates
6.20 Hetero
6.20.1 Hetero Company Information
6.20.2 Hetero Description and Business Overview
6.20.3 Hetero Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Hetero Oncology API Product Portfolio
6.20.5 Hetero Recent Developments/Updates
6.21 Bachem
6.21.1 Bachem Company Information
6.21.2 Bachem Description and Business Overview
6.21.3 Bachem Oncology API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Bachem Oncology API Product Portfolio
6.21.5 Bachem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology API Industry Chain Analysis
7.2 Oncology API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology API Production Mode & Process
7.4 Oncology API Sales and Marketing
7.4.1 Oncology API Sales Channels
7.4.2 Oncology API Distributors
7.5 Oncology API Customers
8 Oncology API Market Dynamics
8.1 Oncology API Industry Trends
8.2 Oncology API Market Drivers
8.3 Oncology API Market Challenges
8.4 Oncology API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Olon Group
PolyPeptide
Glenmark Life Sciences
Sterling
Neopharma
Concord Biotech
Eisai Pharmaceuticals
Aspen API
Dr. Reddy's
CordenPharma
Natco
PROCOS SPA
Biocon
Shivalik Rasayan
Kekule Pharma
Aenova
GLS Pharma
Suanfarma
Fresenius Kabi Oncology
Hetero
Bachem
听
听
*If Applicable.